EMERGENT BIOSOLUTIONS Insider Sale: Routine 10b5‑1 Trade, No Impact on Shares
EMERGENT BIOSOLUTIONS insider sells 17,800 shares under a Rule 10b5‑1 plan for tax purposes, showing routine trading without distress signs.
3 minutes to read
EMERGENT BIOSOLUTIONS INC